Brookings: Series - Brookings Active Surveillance Implementation Council

Brookings Active Surveillance Implementation Council Meeting #4

Wed, 30 Nov 2011 09:00:00 -0500

Event Information

November 30, 2011
9:00 AM - 2:00 PM EST

Saul/Zilkha Rooms
The Brookings Institution
1775 Massachusetts Avenue, NW
Washington, DC 20036

On November 30, the Engelberg Center for Health Care Reform convened a small working group to consider a sustainable and collaborative strategy for advancing safety science through methods research and training.

While meeting participants primarily focused on addressing the more immediate needs of the Sentinel Initiative, they also briefly discussed how future initiatives could build upon Sentinel’s tools and infrastructure to take advantage of electronic health care data’s potential.

Transcript

Event Materials

Participants

Panelists

Rachel Sherman

Center for Drug Evaluation and Research, U.S. Food and Drug Administration

Brookings Active Surveillance Implementation Council Meeting #2

Thu, 18 Nov 2010 08:30:00 -0500

Event Information

November 18, 2010
8:30 AM - 3:30 PM EST

Ballroom
Marriott at Metro Center
775 12th St. NW
Washington, DC

The Brookings Active Surveillance Implementation Council meeting opened with brief summaries of a number of ongoing pilot projects using distributed data systems, including:

Mini-Sentinel
Assistant Secretary for Planning and Evaluation and the Centers for Medicaid & Medicare Services’s multi-payer claims database
National Institute of Health’s HMO Collaboratory
European Medicines Agency-Coordinated PROTECT Project
Observational Medical Outcomes Partnership
Agency for Healthcare Research and Quality’s distributed database work.

Because Sentinel’s success depends on its ability to attract and maintain private sector data and analytic partners, the majority of the meeting focused on ensuring a meaningful and worthwhile experience for these stakeholders. Two guest panels comprised of senior executives from health plans and integrated delivery systems helped to stimulate discussion, as they articulated their concerns and needs for their participation in Sentinel. Council members and guest panelists then explored potential solutions to address these issues, including the possible roles that private sector data and analytic partners may play in the governance of Sentinel.

Transcript

Event Materials

Participants

Panelists

Janet Woodcock

Center for Drug Evaluation and Research, U.S. Food and Drug Administration

Rachel Behrman

Office of Medical Policy, Center for Drug Evaluation and Research, U.S. Food and Drug Administration

Judy Racoosin

Office of Medical Policy, Center for Drug Evaluation and Research, U.S. Food and Drug Administration

Richard Platt

Harvard Medical School and Harvard Pilgrim Health Care Institute

Jean Slutsky

Center for Outcomes and Evidence, Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services

Amol Navathe

Office of the Secretary, U.S. Department of Health and Human Services

Philip Wang

National Institute of Mental Health

Xavier Kurz

Pharmacovigilance and Risk Management Sector, European Medicines Agency

Paul Stang

Johnson & Johnson and Observational Medical Outcomes Partnership

Dennis Ausiello

Harvard Medical School, Massachusetts General Hospital, and Partners Healthcare

Humana

WellPoint, Inc.

UnitedHealth Group

Competitive Health Analytics, Humana

Karen Ignagni

America's Health Insurance Plans

Andrew Slavitt

Ingenix

Stanley Watson

Kaiser Foundation Research Institute

Marcus Wilson

HealthCore

Brookings Active Surveillance Implementation Council Meeting #1

Wed, 02 Jun 2010 08:30:00 -0400

Event Information

June 2, 2010
8:30 AM - 3:30 PM EDT

Stein Room
The Brookings Institution
1775 Massachusetts Avenue, N.W.
Washington, DC 20036

During the first BASIC meeting, Council members received updates on several ongoing pilot activities including the Observational Medical Outcomes Partnership (OMOP), Mini-Sentinel, the Exploring and Understanding Adverse Drug Reactions (EU-ADR) Project, and the Vaccine Safety Datalink.

Recognizing similarities among these pilot activities, the Council considered potential opportunities for sharing findings and minimizing overlap. Following a presentation by McKinsey & Company on lessons learned from public-private partnerships and complex alliances in other industries, the Council discussed governance of the Sentinel System. Specifically, Council members explored the merits of potential organizational models focusing on governance for multiple users and multiple uses, economic sustainability, and ensuring participation of appropriate stakeholders.

Transcript

Event Materials

Participants

Panelists

Janet Woodcock

Center for Drug Evaluation and Research, U.S. Food and Drug Administration

Rachel Behrman

Office of Medical Policy, Center for Drug Evaluation and Research, U.S. Food and Drug Administration

Paul Stang

Johnson & Johnson, Foundation for the National Institutes of Health's Observational Medical Outcomes Partnership

Judy Racoosin

Office of Medical Policy, Center for Drug Evaluation and Research, U.S. Food and Drug Administration

Francesca Cunningham

Center for Medication Safety PSCI, Department of Veterans Affairs National Center for Patient Safety and Pharmacy Benefits Management Services

Trinka Coster

Pharmacovigilance Center, United States Army, Office of the Surgeon General

Richard Platt

Department of Population Medicine at Harvard Medical School and Harvard Pilgrim Health Care Institute

Briggs Morrison

Primary Care Medicines Development Group, Pfizer, Inc.

Arnold Chan

i3 Drug Safety

Myrl Weinberg

National Health Council

Miriam Sturkenboom

Department of Medical Informatics and Epidemiology, Erasmus University Medical Center

Chesley Richards

Office of Prevention through Healthcare, Office of the Director for Policy, Centers for Disease Control and Prevention

Jean Slutsky

Center for Outcomes and Evidence, Agency for Healthcare Research and Quality

Claudia Williams

Office of the National Coordinator for Health Information Technology

Navjot Singh

MicKinsey & Company

Robert Califf

Duke Translational Medicine Institute, Division of Cardiology at Duke University Medical Center

Alec Walker

World Health Information Science Consultants

Stanley Watson

Kaiser Foundation Research Institute

Brookings Active Surveillance Implementation Council Meeting #3

Mon, 01 Jan 0001 00:00:00 -0500

Event Information

Saul/Zilkha Rooms
The Brookings Institution
1775 Massachusetts Avenue, NW
Washington, DC 20036

On June 1, the Engelberg Center hosted the third Brookings Active Surveillance Implementation Council meeting, with Council members gathering to discuss the role of medical product developers in active medical product surveillance and specifically their role in improving methods.

Discussion focused on medical product developer's perspectives, including what role developers want to play in active surveillance and possible approaches for achieving such roles. In addition, participants discussed the role OMOP, Mini-Sentinel, and other federal initiatives have played in addressing developer concerns around methods for active surveillance, as well as types of organizational models that could support a long-term strategy for methods research and development.